default author photo

Hua Zhu

Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA)

Beijing

China

  • Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA)

SCHOLARLY PAPERS

2

DOWNLOADS

153

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Al[ 18F]-AEEA-HER2-BCH Affibody PET Imaging Accurately Depict HER2 Positive Lesions

Number of pages: 23 Posted: 01 Dec 2021
Xiaoyi Guo, Nina Zhou, Jin Ding, Jiayue Liu, Shuailiang Wang, Teli Liu, Guohong Song, Hua Zhu and Zhi Yang
Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Beijing Cancer Hospital, Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA) and Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA)
Downloads 80 (803,225)

Abstract:

Loading...

Al[18F]-HER2-BCH, Breast Cancer, Human Epidermal Growth Factor Receptor 2, PET/CT

2.

Development and First-in-Human Evaluation of a Site-Specific [18f]-Labeled Pd-L1 Nanobody Pet Radiotracer for Noninvasive Imaging in Nsclc

Number of pages: 22 Posted: 08 Jan 2025
Xiaopan Ma, Biao Hu, Xin Zhou, Lei Wang, Hui Chen, Fei Xie, Hua Zhu, Bing Jia and Zhi Yang
Guizhou University, affiliation not provided to SSRN, affiliation not provided to SSRN, Hubei University of Arts and Science - Xiangyang Central Hospital, Hubei University of Arts and Science - Xiangyang Central Hospital, Hubei University of Arts and Science - Xiangyang Central Hospital, Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA), affiliation not provided to SSRN and Peking University - Key Laboratory for Research and Evaluation of Radiopharmaceuticals (NMPA)
Downloads 73 (891,180)

Abstract:

Loading...

PD-L1, PET/CT, Nanobody, NSCLC, RESCA